Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation

Mackey, 1997, Myasthenia gravis in association with allogenic bone marrow transplantation: clinical observations, therapeutic implications and review of literature, Bone Marr Transpl, 19, 939, 10.1038/sj.bmt.1700759

Atassi, 2008, Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation, Muscle Nerve, 38, 1074, 10.1002/mus.21023

Oh Sh, 2009, Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status, J Clin Neurol, 5, 53, 10.3988/jcn.2009.5.2.53

Baron, 1998, Myasthenia gravis without chronic GVHD after allogenic bone marrow transplantation, Bone Marr Transpl, 2, 197, 10.1038/sj.bmt.1701297

Dowell, 1999, Myasthenia gravis after allogenic bone marrow transplantation for lymphoblastic lymphoma, Bone Marr Transpl, 24, 1359, 10.1038/sj.bmt.1702067

Kotani, 2002, Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40_ CD4_ T cells, Eur J Haematol, 69, 318, 10.1034/j.1600-0609.2002.02789.x

Smith, 1983, Myasthenia gravis after bone marrow transplantation. Evidence for a donor origin, N Engl J Med, 309, 1565, 10.1056/NEJM198312223092508

Tse, 1999, Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host disease, Bone Marr Transpl, 23, 397, 10.1038/sj.bmt.1701575

Yanagihara, 2001, A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis, Rinsho Shinkeigaku, 41, 503

Grover, 2012, Muscle-specific kinase-antibody positive myasthenia gravis after autologous bone marrow transplantation, Clin Neuromusc Dis, 13, 146, 10.1097/CND.0b013e31821c560e

Vincent, 2008, Myasthenia gravis seronegative for acetylcholine receptor antibodies, Ann N Y Acad Sci, 1132, 84, 10.1196/annals.1405.020

Ma, 2012, Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation, Biol Blood Marr Transpl, 18, 1174, 10.1016/j.bbmt.2012.05.014

Kumar, 2007, Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis, Ann Oncol, 18, 804, 10.1093/annonc/mdm010

Zaja, 1995, Myasthenia gravis after allogeneic bone marrow transplantation: a case report, Bone Marr Transpl, 15, 649

Adams, 1995, Neuromuscular complications of bone marrow transplantation, Pediat Neurol, 12, 58, 10.1016/0887-8994(94)00097-L

Shimoda, 1994, Myasthenia gravis after allogeneic bone marrow transplantation, Bone Marr Transpl, 14, 155

Haslam, 1993, Immune complex glomerulonephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation, Nephrol Dial Transpl, 8, 1390

Melms, 1992, Myasthenia gravis after BMT: identification of patients at risk?, Bone Marr Transpl, 9, 78

Abecassis, 1991, Complicac¸oes pouco habituais da transplantacao de medula ossea (TMO). Experieˆncia da Unidade de TMO do Instituo Portugueˆs de Oncologia de Francisco Gentil, Centro de Lisboa, Acta Med Portuguesa, 4, 37

Grau, 1990, Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations, Bone Marr Transpl, 5, 435

Atkinson, 1989, Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease, Bone Marr Transpl, 4, 129

Lefvert, 1987, Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting, N Engl J Med, 317, 170, 10.1056/NEJM198707163170314

Bolger, 1986, Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease, Neurology, 36, 1087, 10.1212/WNL.36.8.1087

Seely, 1984, Post bone marrow transplantation (BMT) myasthenia gravis: evidence for acetylcholine receptor (AChR) abnormality. Abstract, Blood, 64, 221a